Adaptimmune stock plunges after announcing Nasdaq delisting plans
Investing.com - BMO Capital maintained its Outperform rating and $280.00 price target on Salesforce.com (NYSE:CRM), currently trading at $246, following the company’s Financial Analyst day. According to InvestingPro data, the stock appears undervalued based on its Fair Value analysis.
The research firm expressed increased optimism after the event, noting that Salesforce presented a "solid foundation" for potential growth and margin improvements over the coming years, despite current negative investor sentiment surrounding the company. This optimism is supported by Salesforce’s impressive 77.65% gross profit margins and perfect Piotroski Score of 9, as reported by InvestingPro.
BMO highlighted Salesforce’s established business logic and data in core product offerings as strengths, along with improving Agentforce capabilities and expanding pricing structures that could drive better growth performance.
The firm acknowledged that Agentforce adoption remains in early stages, with demand metrics unlikely to show significant improvement until fiscal year 2027.
BMO Capital maintained its positive outlook on Salesforce with the $280 target price, suggesting confidence in the company’s long-term trajectory despite near-term adoption challenges.
In other recent news, Salesforce has been the focus of several analyst reports and strategic updates. Goldman Sachs reiterated its Buy rating on Salesforce, maintaining a price target of $385. This follows the company’s Analyst Day, where Salesforce provided long-term guidance aiming for over $60 billion in revenue by fiscal 2030, with a projected compound annual growth rate of approximately 10% and operating margins expected to reach around 40%. Cantor Fitzgerald also reaffirmed its Overweight rating with a $325 price target, highlighting Salesforce’s enterprise AI strategy, particularly the launch of Agentforce 360, which integrates enterprise data, agents, assistants, and workflow automation.
Meanwhile, Citizens maintained its Market Outperform rating with a price target of $430, citing Salesforce’s focus on delivering the "agentic enterprise" across multiple industries. UBS kept its Neutral rating and $260 price target, describing the Investor Day at the Dreamforce event as a "net positive." DA Davidson reiterated its Neutral rating with a $225 price target, noting updates on innovation acceleration and new long-term financial targets presented at the same event. These developments provide a comprehensive view of Salesforce’s current strategic positioning and future growth prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.